Question to the Department of Health and Social Care:

To ask His Majesty's Government what assessment they have made of the higher risk of prostate cancer in black men, and what steps they are taking to provide support to black men with a higher risk profile.

The Government understands that more needs to be done to improve outcomes for all people with prostate cancer, including black men, who we know are two to three times more likely to develop prostate cancer than white men.

To address disparities and find ways to better detect prostate cancer earlier, we have invested £16 million in the United Kingdom-wide TRANSFORM trial, aimed at helping to find the best ways of detecting prostate cancer in men, even if they are not displaying any symptoms. This research will aim to address some of the inequalities that exist in prostate cancer diagnosis by targeting black men in trial recruitment, ensuring that one in ten participants are black men. We have also asked the National Screening Committee to review the evidence for introducing prostate cancer screening, including for high-risk groups.